Revolution Medicines (RVMD) Enterprise Value: 41.52B

Revolution Medicines, Inc. (RVMD)

206.64 +0.75 (+0.36%) USD | NASDAQ | Oct 02, 16:00

206.50 -0.14 (-0.07%) After-Hours: 20:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2020. Start Trial.

Date	Value
October 02, 2026	41.52B
October 01, 2026	41.36B
September 30, 2026	41.23B
September 29, 2026	41.06B
September 28, 2026	40.47B
September 25, 2026	41.17B
September 24, 2026	40.07B
September 23, 2026	38.12B
September 22, 2026	38.57B
September 21, 2026	38.55B
September 18, 2026	38.16B
September 17, 2026	39.45B
September 16, 2026	39.23B
September 15, 2026	41.14B
September 14, 2026	41.20B
September 11, 2026	40.91B
September 10, 2026	40.82B
September 09, 2026	41.75B
September 08, 2026	41.67B
September 04, 2026	42.25B
September 03, 2026	42.43B
September 02, 2026	42.08B
September 01, 2026	42.22B
August 31, 2026	41.29B
August 28, 2026	41.79B

Date	Value
August 27, 2026	44.63B
August 26, 2026	43.41B
August 25, 2026	42.54B
August 24, 2026	42.58B
August 21, 2026	42.13B
August 20, 2026	42.62B
August 19, 2026	43.24B
August 18, 2026	43.53B
August 17, 2026	42.67B
August 14, 2026	40.90B
August 13, 2026	40.53B
August 12, 2026	41.23B
August 11, 2026	41.29B
August 10, 2026	41.59B
August 07, 2026	41.20B
August 06, 2026	39.63B
August 05, 2026	39.52B
August 04, 2026	38.70B
August 03, 2026	36.34B
July 31, 2026	37.43B
July 30, 2026	38.42B
July 29, 2026	36.01B
July 28, 2026	36.64B
July 27, 2026	37.55B
July 24, 2026	37.79B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks